A 3-year follow-up of a prospective randomized trial comparing transurethral electrovaporization of the prostate with standard transurethral prostatectomy

BJU International

Volumn 86, Issue 6, 2000, Pages 648-651

  Hammadeh, M Y ^a,b   Madaan, S ^a   Singh, M ^a   Philp, T ^a  

^a WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Complications; Electrovaporization; Outcome; TURP

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; IMPOTENCE; INTERMETHOD COMPARISON; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; RETROGRADE EJACULATION; SAFETY; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SURGICAL APPROACH; SURGICAL TECHNIQUE; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE FLOW RATE;

AGED; ELECTROCOAGULATION; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0033771779     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00879.x     Document Type: Article

References (22)

1. Neal DE. The National Prostatectomy Audit. Br J Urol 1997;79 (Suppl. 2): 69-75
2. Holtgrewe HL. The economics of the management of lower urinary tract symptoms and benign prostatic hyperplasia. In Denis L, Griffiths K, Khoury S et al. eds, 4th International Consultation on Benign Prostatic Hyperplasia (BPH). Health Publication Ltd, 1997: 63-81
3. Holtgrewe HL. Transurethral prostatectomy. Urol Clin North Am 1995; 22: 357-68
4. Mebust W, Holtgrewe H, Cockett APC et al. Transurethral prostatectomy: Immediate and postoperative complication. A comparative study of 13 participating institution evaluating, 3,885 patients. J Urol 1989; 141: 243-7
5. McConnell JD, Barry MJ, Bruskewitz RC et al. Benign prostatic hyperplasia: Diagnosis and treatment. Clinical Practice Guideline. No 8. AHCPR publication no. 94-0582. Rockville, MD. Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1994
6. Kaplan SA, Te AE. Transurethral electrovaporisation of the prostate (TVP): a novel method for treating men with benign prostatic hyperplasia. Urology 1995; 45: 566-71
7. Stewart SC, Benjamin D, Ruckle H et al. Electrovaporisation of the prostate: New technique for treatment of symptomatic benign hyperplasia. J Endourol 1995; 9: 413-6
8. Tewari A, Narayan P. Electrovaporisation of the prostate. Br J Urol 1996; 78: 667-76
9. Kaplan S, Santorosa P, Te AE. Transurethral electrovaporization of the prostate: One-year experience. Urology 1996; 48: 876-81
10. Thomas KJ, Cornaby AJ, Hammadeh MY et al. Transurethral vaporisation of the prostate: a promising new technique. Br J Urol 1997; 79: 186-9
11. Hammadeh MY, Fowlis GA, Singh M, Philp T. Transurethral electrovaporization of the prostate - a possible alternative to transurethral resection: a one-year follow-up of a prospective randomized trial. Br J Urol 1998; 81: 721-5
12. Kaplan SA. Minimally invasive alternative therapeutic options for lower urinary tract symptoms. Urology 1998: 51 (Suppl. 4A): 32
13. Galucci M, Puppo P, Perachino M et al. Transurethral electrovaporisation of the prostate vs. transurethral resection. Eur Urol 1998; 33: 359-64
14. Wasson JH, Reda DJ, Bruskewttz RC et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of BPH. N Engl J Med 1995: 332: 75-9
15. Kaplan SA, Laor E, Fatal M, Te AE. Transurethral resection of the prostate versus transurethral electrovaporisation of the prostate: a blinding, prospective comparative study with 1-year follow up. J Urol 1998; 159: 454-8
16. Shokier AA, Al-Sisi H, Farage YM, El-Maaboud MA, Saeed M, Mutabagani H. Transurethral prostatectomy: a prospective randomised study of conventional resection and electrovaporisation in benign prostatic hyperplasia. Br J Urol 1997; 80: 570-4
17. Kupeli B, Yalcinkaya F, Topaloglu H et al. Efficacy of transurethral electrovaporisation of the prostate with respect to standard transurethral resection. J Endourol 1998; 12: 591-4
18. Fortunato P, Marcello M, Manlio S et al. Transurethral electrovaporisation of the prostate with VaporTrode VE-B (TUVP): follow up at 12 months. Eur Urol 1996; 30: 111
19. Perlmutter AP, Muschter R, Razvi HA. Electrosurgical vaporisation of the prostate in the canine model. Urology 1995; 46: 518-23
20. Patel A, Fuches GJ, Gutierrez-Aceves J, Ryan TP. Prostate heating patterns comparing electrosurgical transurethral resection and vaporization: a prospective randomised study. J Urol 1997; 157: 169-72
21. Desautel MG, Burney TL, Diaz PA, Austria A, Badlani G. Outcome of VaporTrode transurethral vaporisation of the prostate using pressure-flow urodynamic criteria. Urology 1998; 51: 1013-7
22. Roos NP, Wennberg JE, Malenka DJ et al. Mortality and reoperation after open and transurethral resection of the prostate for BPH. N Enal J Med 1989; 320: 1120-4